Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
TONABERSAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TONABERSAT
×
Maximum Phase:
2
First Approval:
None
UNII:
2XD9773ZMN
Molecule Type:
Small molecule
Molecular Formula:
C20H19ClFNO4
Molecular Weight:
391.83
AlogP:
3.68
PSA:
75.63
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PROPIONIC ACID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PROPIONIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
JHU490RVYR
Molecule Type:
Small molecule
Molecular Formula:
C3H6O2
Molecular Weight:
74.08
AlogP:
0.48
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
BUTAMIRATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BUTAMIRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SONEDENOSON
(2)
Small molecule
Adenosine A2a receptor agonist
Unknown
Investigational
Unknown
SONEDENOSON
×
Maximum Phase:
2
First Approval:
None
UNII:
2OT4KAG5JL
Molecule Type:
Small molecule
Molecular Formula:
C18H20ClN5O5
Molecular Weight:
421.84
AlogP:
0.29
PSA:
148.77
HBD:
4.0
HBA:
#RotB:
6.0
Source:
EMRICASAN
(2)
Small molecule
Caspase inhibitor
Unknown
Investigational
Unknown
EMRICASAN
×
Maximum Phase:
2
First Approval:
None
UNII:
P0GMS9N47Q
Molecule Type:
Small molecule
Molecular Formula:
C26H27F4N3O7
Molecular Weight:
569.51
AlogP:
2.59
PSA:
150.9
HBD:
4.0
HBA:
#RotB:
10.0
Source:
MPC-5971
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
MPC-5971
×
Maximum Phase:
2
First Approval:
None
UNII:
85I4FF980A
Molecule Type:
Small molecule
Molecular Formula:
C18H20K2MgO21
Molecular Weight:
674.84
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LGD-6972
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LGD-6972
×
Maximum Phase:
2
First Approval:
None
UNII:
6IJ842I0Z2
Molecule Type:
Small molecule
Molecular Formula:
C43H46N2O5S
Molecular Weight:
702.92
AlogP:
8.83
PSA:
112.57
HBD:
3.0
HBA:
#RotB:
11.0
Source:
ETARFOLATIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ETARFOLATIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
40UB1H6Q6T
Molecule Type:
Small molecule
Molecular Formula:
C29H34N10O11S
Molecular Weight:
730.72
AlogP:
-2.86
PSA:
337.88
HBD:
11.0
HBA:
#RotB:
19.0
Source:
GALLIUM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GALLIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
CH46OC8YV4
Molecule Type:
Small molecule
Molecular Formula:
Ga
Molecular Weight:
69.72
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VOFOPITANT
(2)
Small molecule
Neurokinin 1 receptor antagonist
Unknown
Investigational
Unknown
VOFOPITANT
×
Maximum Phase:
2
First Approval:
None
UNII:
K08BK043YS
Molecule Type:
Small molecule
Molecular Formula:
C21H23F3N6O
Molecular Weight:
432.45
AlogP:
3.27
PSA:
76.89
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CX-157
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CX-157
×
Maximum Phase:
2
First Approval:
None
UNII:
O6L62LZJ0Q
Molecule Type:
Small molecule
Molecular Formula:
C14H8F4O4S
Molecular Weight:
348.27
AlogP:
3.71
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
2.0
Source:
TRIACETIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TRIACETIN
×
Maximum Phase:
2
First Approval:
None
UNII:
XHX3C3X673
Molecule Type:
Small molecule
Molecular Formula:
C9H14O6
Molecular Weight:
218.21
AlogP:
0.04
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
5.0
Source:
NANATINOSTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NANATINOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
YTL7A418KQ
Molecule Type:
Small molecule
Molecular Formula:
C20H19FN6O2
Molecular Weight:
394.41
AlogP:
1.51
PSA:
103.27
HBD:
3.0
HBA:
#RotB:
5.0
Source:
BAVISANT DIHYDROCHLORIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BAVISANT DIHYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
C1H7H5X3RE
Molecule Type:
Small molecule
Molecular Formula:
C19H31Cl2N3O3
Molecular Weight:
420.38
AlogP:
1.44
PSA:
36.02
HBD:
0.0
HBA:
#RotB:
4.0
Source:
VODOBATINIB
(2)
Small molecule
Bcr/Abl fusion protein inhibitor
Unknown
Investigational
Unknown
VODOBATINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
N8Q12KU2SW
Molecule Type:
Small molecule
Molecular Formula:
C27H20ClN3O2
Molecular Weight:
453.93
AlogP:
4.98
PSA:
71.09
HBD:
2.0
HBA:
#RotB:
2.0
Source:
TC-6987
(2)
Small molecule
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
Unknown
Investigational
Unknown
TC-6987
×
Maximum Phase:
2
First Approval:
None
UNII:
Q2U4R164OG
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAPANSUTRILE
(2)
Small molecule
NACHT, LRR and PYD domains-containing protein 3 inhibitor
Unknown
Investigational
Unknown
DAPANSUTRILE
×
Maximum Phase:
2
First Approval:
None
UNII:
2Z03364G96
Molecule Type:
Small molecule
Molecular Formula:
C4H7NO2S
Molecular Weight:
133.17
AlogP:
-0.06
PSA:
57.93
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ORVEPITANT MALEATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ORVEPITANT MALEATE
×
Maximum Phase:
2
First Approval:
None
UNII:
HAX0H28B6W
Molecule Type:
Small molecule
Molecular Formula:
C35H39F7N4O6
Molecular Weight:
744.71
AlogP:
6.8
PSA:
47.1
HBD:
0.0
HBA:
#RotB:
4.0
Source:
2-AMINO-3-HYDROXY-3-(PYRIDIN-4-YL)-1-(PYRROLIDIN-1-YL)PROPAN-1-ONE, (2R,3S)-
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
2-AMINO-3-HYDROXY-3-(PYRIDIN-4-YL)-1-(PYRROLIDIN-1-YL)PROPAN-1-ONE, (2R,3S)-
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZED-1227
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ZED-1227
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AT-7519
(2)
Small molecule
Cyclin-dependent kinase inhibitor
Unknown
Investigational
Unknown
AT-7519
×
Maximum Phase:
2
First Approval:
None
UNII:
X1BF92PW9T
Molecule Type:
Small molecule
Molecular Formula:
C16H17Cl2N5O2
Molecular Weight:
382.25
AlogP:
2.45
PSA:
98.91
HBD:
4.0
HBA:
#RotB:
4.0
Source:
VALOPICITABINE
(2)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Investigational
Unknown
VALOPICITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
I2T0B5G94M
Molecule Type:
Small molecule
Molecular Formula:
C15H24N4O6
Molecular Weight:
356.38
AlogP:
-1.64
PSA:
162.92
HBD:
4.0
HBA:
#RotB:
5.0
Source:
PIMASERTIB
(2)
Small molecule
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
Unknown
Investigational
Unknown
PIMASERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
6ON9RK82AL
Molecule Type:
Small molecule
Molecular Formula:
C15H15FIN3O3
Molecular Weight:
431.21
AlogP:
1.65
PSA:
94.48
HBD:
4.0
HBA:
#RotB:
6.0
Source:
ATSM COPPER (II)
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ATSM COPPER (II)
×
Maximum Phase:
2
First Approval:
None
UNII:
0YDK1H9L3A
Molecule Type:
Small molecule
Molecular Formula:
C8H14CuN6S2
Molecular Weight:
321.92
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MODITHROMYCIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
MODITHROMYCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
9MAY4E090U
Molecule Type:
Small molecule
Molecular Formula:
C43H64N6O11
Molecular Weight:
841.02
AlogP:
3.7
PSA:
205.72
HBD:
2.0
HBA:
#RotB:
8.0
Source:
ZIMLOVISERTIB
(2)
Small molecule
Interleukin-1 receptor-associated kinase 4 inhibitor
Unknown
Investigational
Unknown
ZIMLOVISERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
S3F315JJXI
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN3O4
Molecular Weight:
361.37
AlogP:
1.58
PSA:
103.54
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PF-04937319
(2)
Small molecule
Hexokinase type IV activator
Unknown
Investigational
Unknown
PF-04937319
×
Maximum Phase:
2
First Approval:
None
UNII:
7E99B9ZM19
Molecule Type:
Small molecule
Molecular Formula:
C22H20N6O4
Molecular Weight:
432.44
AlogP:
3.38
PSA:
123.34
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PACTIMIBE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PACTIMIBE
×
Maximum Phase:
2
First Approval:
None
UNII:
D874R9PZ9T
Molecule Type:
Small molecule
Molecular Formula:
C25H40N2O3
Molecular Weight:
416.61
AlogP:
5.64
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
10.0
Source:
E-6201
(2)
Small molecule
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
Unknown
Investigational
Unknown
E-6201
×
Maximum Phase:
2
First Approval:
None
UNII:
CZP9GB25HO
Molecule Type:
Small molecule
Molecular Formula:
C21H27NO6
Molecular Weight:
389.45
AlogP:
2.27
PSA:
116.09
HBD:
4.0
HBA:
#RotB:
2.0
Source:
PG-530742
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PG-530742
×
Maximum Phase:
2
First Approval:
None
UNII:
F94T42GL80
Molecule Type:
Small molecule
Molecular Formula:
C24H27N3O7S
Molecular Weight:
501.56
AlogP:
1.4
PSA:
134.27
HBD:
3.0
HBA:
#RotB:
9.0
Source:
CP-195543
(2)
Small molecule
Leukotriene B4 receptor antagonist
Unknown
Investigational
Unknown
CP-195543
×
Maximum Phase:
2
First Approval:
None
UNII:
YB1F0V77MK
Molecule Type:
Small molecule
Molecular Formula:
C24H19F3O4
Molecular Weight:
428.41
AlogP:
5.36
PSA:
66.76
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TUCARESOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TUCARESOL
×
Maximum Phase:
2
First Approval:
None
UNII:
JH368G5B9M
Molecule Type:
Small molecule
Molecular Formula:
C15H12O5
Molecular Weight:
272.26
AlogP:
2.48
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
5.0
Source:
FOSBRETABULIN DISODIUM
(2)
Small molecule
Tubulin inhibitor
Unknown
Investigational
Unknown
FOSBRETABULIN DISODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
702RHR475O
Molecule Type:
Small molecule
Molecular Formula:
C18H19Na2O8P
Molecular Weight:
440.3
AlogP:
3.36
PSA:
103.68
HBD:
2.0
HBA:
#RotB:
8.0
Source:
AZD-4573
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AZD-4573
×
Maximum Phase:
2
First Approval:
None
UNII:
E5XSP3X68B
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClN5O2
Molecular Weight:
429.95
AlogP:
3.81
PSA:
88.91
HBD:
2.0
HBA:
#RotB:
4.0
Source:
DOMATINOSTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DOMATINOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
264ARM7UXX
Molecule Type:
Small molecule
Molecular Formula:
C23H21N5O3S
Molecular Weight:
447.52
AlogP:
3.36
PSA:
112.01
HBD:
2.0
HBA:
#RotB:
6.0
Source:
MOTOLIMOD
(2)
Small molecule
Toll-like receptor 8 agonist
Unknown
Investigational
Unknown
MOTOLIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
WP6PY72ZH3
Molecule Type:
Small molecule
Molecular Formula:
C28H34N4O2
Molecular Weight:
458.61
AlogP:
5.01
PSA:
79.0
HBD:
1.0
HBA:
#RotB:
7.0
Source:
1
2
…
127
128
129
130
131
132
133
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA